Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: BioGaia AB

Market Cap 11.96B 1.25B 1.09B 1.01B 945M 1.77B 118B 1.78B 4.64B 58.12B 4.7B 4.6B 201B P/E 2026 *
28.3x
P/E 2027 * 23.7x
Enterprise Value 11.21B 1.17B 1.02B 942M 886M 1.66B 111B 1.67B 4.35B 54.49B 4.4B 4.31B 189B EV / Sales 2026 *
6.73x
EV / Sales 2027 * 6x
Free-Float
75.89%
Yield 2026 *
3.55%
Yield 2027 * 3.81%
1 day+0.42%
1 week-4.83%
Current month-9.29%
1 month-9.08%
3 months+2.78%
6 months+17.38%
Current year+11.30%
1 week 114.6
Extreme 114.6
126
1 month 114.6
Extreme 114.6
136.3
Current year 97.5
Extreme 97.5
136.3
1 year 93.2
Extreme 93.2
136.3
3 years 91.45
Extreme 91.45
139.7
5 years 68.88
Extreme 68.88
139.7
10 years 42.2
Extreme 42.2
139.7
Manager TitleAgeSince
Chief Executive Officer 60 2023-09-29
Director of Finance/CFO 59 2019-11-04
Chief Operating Officer 49 2020-12-31
Director TitleAgeSince
Chairman 77 2002-12-31
Chairman 76 2018-04-24
Director/Board Member 46 2014-12-31
Date Insider Type Main position Quantity % Market Cap.
02-12Buy

Director

582 0.0006%
12-29Buy

General Counsel

390 0.0004%
12-04Buy

Director

5,000 0.0051%
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%-4.83%+17.15%+3.05% 1.27B
+0.33%-0.25%+18.76%-22.11% 61.85B
-1.27%-8.04%+60.62%+190.51% 55.69B
+4.38%+43.00%+43.00%+43.00% 41.88B
+2.04%+2.73%-53.73%-61.17% 36.15B
-1.05%-1.69%+55.35%-33.92% 29.33B
+3.50%+28.85%+151.81%-50.31% 24.52B
-0.78%-8.91%+43.87%+55.34% 19.78B
+1.74%+4.39%-3.12%+107.49% 16.61B
-0.05%+0.41%+56.32%+94.95% 16.2B
Average +0.94%+2.30%+39.00%+32.68% 30.33B
Weighted average by Cap. +0.92%+2.21%+37.89%+36.35%

Financials

2026 *2027 *
Net sales 1.67B 174M 152M 140M 132M 247M 16.44B 248M 647M 8.1B 655M 641M 28.08B 1.86B 195M 170M 157M 147M 275M 18.36B 277M 723M 9.05B 731M 716M 31.37B
Net income 423M 44.27M 38.57M 35.55M 33.44M 62.56M 4.17B 63M 164M 2.06B 166M 163M 7.13B 504M 52.74M 45.95M 42.36M 39.85M 74.54M 4.97B 75.07M 196M 2.45B 198M 194M 8.49B
Net Debt -746M -78.07M -68.02M -62.7M -58.98M -110M -7.36B -111M -290M -3.63B -293M -287M -12.57B -785M -82.15M -71.58M -65.98M -62.06M -116M -7.74B -117M -305M -3.82B -308M -302M -13.22B
Logo BioGaia AB
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
Employees
243
Date Price Change Volume
26-06-18 118.20 kr +0.42% 136,948
26-06-17 117.70 kr +1.55% 142,913
26-06-16 115.90 kr -4.77% 388,245
26-06-15 121.70 kr -2.25% 111,484
26-06-12 124.50 kr +0.24% 112,435
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
118.20SEK
Average target price
165.00SEK
Spread / Average Target
+39.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIOG B Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!